celecoxib has been researched along with thromboplastin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bea, F; Bennett, BJ; Blessing, E; Campbell, LA; Kreuzer, J; Kuo, CC; Rosenfeld, ME | 1 |
Gay, S; Greutert, H; Hermann, M; Lüscher, TF; Ruschitzka, F; Steffel, J; Tanner, FC | 1 |
Akhmedov, A; Fähndrich, C; Lüscher, TF; Ruschitzka, F; Steffel, J; Tanner, FC | 1 |
Ai, Y; Dey, SK; Ghosh, M; Hla, T; Luyendyk, JP; Mackman, N; Peters, JM; Romeo, E; Wang, H | 1 |
Chen, HN; Huang, YT; Wan, YL; Wang, HY; Yang, YM; Zhuang, Y | 1 |
Kaneshiro, T; Kawamori, T; Maalouf, S; Maruyama, T; Okumura, M; Uflacker, A | 1 |
Abo-Elmatty, DM; Ahmed, AA; El-Baz, AA; Mosaad, SM; Moustafa, YM; Zaitone, SA | 1 |
7 other study(ies) available for celecoxib and thromboplastin
Article | Year |
---|---|
Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis.
Topics: Actins; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Arteriosclerosis; Brachiocephalic Trunk; Celecoxib; Chemokine CCL2; Cholesterol; Cyclooxygenase 2; Isoenzymes; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thromboplastin; Treatment Failure | 2003 |
Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
Topics: Aorta; Celecoxib; Cells, Cultured; Cyclooxygenase Inhibitors; Endothelium, Vascular; Humans; JNK Mitogen-Activated Protein Kinases; Lactones; Mitogen-Activated Protein Kinases; Phosphorylation; Pyrazoles; Signal Transduction; Sulfonamides; Sulfones; Thromboplastin; Tumor Necrosis Factor-alpha | 2005 |
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Celecoxib; Cell Line; Endothelium, Vascular; Gene Expression Regulation; Heart Diseases; Humans; Lactones; Muscle, Smooth, Vascular; Pyrazoles; Sulfonamides; Sulfones; Thromboplastin; Thrombosis; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2006 |
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation.
Topics: Animals; Cannabinoid Receptor Modulators; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Endothelial Cells; HCT116 Cells; Humans; Mice; PPAR delta; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thromboplastin; Transcription, Genetic; Transcriptional Activation | 2007 |
The effect of celecoxib on tissue factor expression in pancreatic cancer cells.
Topics: Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation; Humans; NF-kappa B; Pancreatic Neoplasms; Pyrazoles; Sulfonamides; Thromboplastin; Tumor Necrosis Factor-alpha | 2007 |
Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells.
Topics: Blood Coagulation; Bridged Bicyclo Compounds; Caproates; Cardiovascular Diseases; Celecoxib; Cell Line; Cytokines; Dinoprostone; Endothelial Cells; Epoprostenol; Fibrinolytic Agents; Gene Expression Regulation; Humans; Peroxisome Proliferator-Activated Receptors; Pyrazoles; Receptors, Prostaglandin E; Response Elements; Signal Transduction; Sulfonamides; Thromboplastin | 2009 |
Evening primrose oil or forskolin ameliorates celecoxib-enhanced upregulation of tissue factor expression in mice subjected to lipopolysaccharide-induced endotoxemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Celecoxib; Colforsin; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endotoxemia; Fibrinolytic Agents; gamma-Linolenic Acid; Linoleic Acids; Lipopolysaccharides; Lung; Male; Mice; Oenothera biennis; Peptide Hydrolases; Plant Oils; Thromboplastin; Thrombosis; Up-Regulation | 2017 |